Semaglutide acts on GLP-1 receptors involved in appetite, digestion, and blood-sugar regulation. This activity may help reduce appetite, increase feelings of fullness, and support reduced food intake as part of an individualized weight-management plan.

Tirzepatide acts on both GIP and GLP-1 receptors, which are involved in appetite and metabolic regulation. Through these pathways, it may help promote feelings of fullness, reduce appetite and food intake, and support an individualized approach to weight management.

Medication is only one part of the process. At LAC Aesthetics, treatment begins with an individualized medical evaluation and may include nutrition, lifestyle guidance, ongoing monitoring, and prescription medication when medically appropriate.

Important: Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality prior to marketing. Treatment recommendations are individualized, and results may vary.

GLP-1–based medications may cause side effects, particularly when beginning treatment or after a dose increase. Common side effects may include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort or pain

• Indigestion or upset stomach

• Decreased appetite

Side effects and individual responses can vary. Your medical history, potential risks, medication interactions, and appropriate treatment options will be reviewed during your consultation. Contact your healthcare provider if you experience persistent, severe, or concerning symptoms.

Results vary from person to person. With an individualized weight-management plan, some patients may experience reduced appetite, increased feelings of fullness, and gradual changes in weight over time.

Your response may depend on several factors, including your starting weight, medication tolerance, nutrition, physical activity, medical history, and consistency with treatment.

Progress is monitored regularly, and your treatment plan may be adjusted based on your individual response and goals. No specific amount or rate of weight loss is guaranteed.

GLP-1–based weight-management therapy may be considered for adults who are looking for medical support with weight management and have not achieved their goals through lifestyle changes alone.

You may be a potential candidate if you:

• Have overweight or obesity, particularly when accompanied by weight-related health concerns

• Have struggled to achieve or maintain weight loss with nutrition and physical activity alone

• Are willing to incorporate healthy nutrition, physical activity, and lifestyle changes into your treatment plan

• Are medically appropriate for GLP-1–based therapy following an individualized evaluation

Not everyone is a candidate. Your medical history, current medications, treatment goals, potential contraindications, and risks will be reviewed before any medication is prescribed.

Every patient responds differently. Some patients may notice changes in appetite or feelings of fullness within the first few weeks of treatment, while changes in weight typically occur gradually over time.

GLP-1–based medications are generally started at a lower dose and adjusted gradually based on individual response and tolerability. Your progress will be monitored throughout treatment, and your plan may be adjusted as medically appropriate.

Results depend on several factors, including nutrition, physical activity, starting weight, medication response, and consistency with treatment. Individual results vary, and no specific amount or rate of weight loss is guaranteed.

At LAC Aesthetics, GLP-1-based medications offered for weight management are administered by subcutaneous injection meaning the medication is injected into the fatty tissue just beneath the skin.

Treatment is individualized, and dosing is determined by your healthcare provider based on your medical history, response to treatment, and tolerability. Patients receive education on proper administration and are monitored throughout their weight-management journey.

Compounded medications are not FDA-approved. Individual treatment and results may vary.

GLP-1–based medications may not be appropriate for everyone. Treatment may not be recommended, or may require additional medical evaluation, for individuals who:

• Are pregnant, planning pregnancy, or breastfeeding

• Have a personal or family history of medullary thyroid carcinoma (MTC)

• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Have had a serious allergic reaction to the medication or its ingredients

• Have a history of pancreatitis or certain pancreatic conditions

• Have severe gastrointestinal disease or significant problems with delayed stomach emptying (gastroparesis)

• Have certain gallbladder, kidney, or other medical conditions requiring additional evaluation

• Take medications or have medical conditions that could affect the safety or appropriateness of treatment

Before treatment, your healthcare provider will review your medical history, medications, allergies, and individual risk factors to determine whether GLP-1–based therapy is appropriate for you.